{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-041775","form_type":"8-K","ticker":"TVGN","cik":"0001860871","company_name":"Tevogen Bio Holdings Inc.","filed_at":"2023-11-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:31.161793+00:00","generated_at":"2026-06-08T00:25:55.524741+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"low","headline":"Semper Paratus furnishes investor presentation for proposed Tevogen Bio merger","bullets":["Presentation provides additional detail on June 28, 2023 merger agreement between SPAC and Tevogen Bio.","Transaction involves exchange of all Tevogen Bio capital stock for Semper Paratus Class A shares.","Closing conditions include shareholder approval, regulatory clearances, and minimum cash requirements.","No new financial projections or material updates disclosed in this filing beyond the presentation."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-041775","json":"https://secwatch.observer/filing/0001493152-23-041775.json","markdown":"https://secwatch.observer/filing/0001493152-23-041775.md","text":"https://secwatch.observer/filing/0001493152-23-041775.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1860871/000149315223041775/0001493152-23-041775-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1860871/000149315223041775/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T00:25:55.524741+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}